A Safety and Efficacy Study of NicaPlant® in Aneurysmal Subarachnoid Haemorrhage Patients Undergoing Aneurysm Clipping

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This study of NicaPlant® is conducted in patients who have a subarachnoid haemorrhage. Patients will be randomized in two treatment groups. Both groups will receive the standard of care and the investigational group will receive in addition NicaPlant®. NicaPlant® is tested to reduce the long-term complications of aneurysmal subarachnoid haemorrhage (aSAH).
Epistemonikos ID: 9fd0ff5588625177c9ac5d455ff526472a8870ea
First added on: May 07, 2024